Preclinical and Clinical Development of (+)-SJ000557733, A Novel Inhibitor of Plasmodium ATP4

Pharmacology, Toxicology and Pharmaceutical Science

1. Adverse Event 50%
2. Anemia 50%
3. Dog 50%
4. Drug 50%
5. Malaria 100%
6. Methemoglobinemia 50%
7. Minimum Inhibitory Concentration 50%
8. Parasite 50%
9. Pharmacodynamics 50%
10. Pharmacokinetics 50%
11. Plasmodium 100%
12. Tablet 50%
13. Tolerability 50%
14. Toxicology 50%